XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Apr. 22, 2022
Apr. 10, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Schedule Of Capitalization Equity [Line Items]                    
Common stock, par value (in dollars per share)     $ 0.001   $ 0.001     $ 0.001    
Common stock, shares authorized (in shares)     150,000,000   150,000,000     150,000,000    
Common stock, shares issued (in shares)     37,175,665   37,175,665     32,682,342    
Common stock, shares outstanding (in shares)     37,175,665   37,175,665     32,682,342    
Proceeds from common stock issued         $ 4,000 $ 47,153,000        
Warrant liabilities fair value adjustment     $ (8,214,000) $ (9,682,000) 13,459,000 $ (19,712,000)        
Warrant liabilities     $ 32,100,000   $ 32,100,000     $ 18,600,000    
Common Stock                    
Schedule Of Capitalization Equity [Line Items]                    
Common stock, shares outstanding (in shares)     37,175,665 32,596,403 37,175,665 32,596,403 33,327,627 32,682,342 29,221,158 28,705,334
Common stock issued, net of expenses (in shares)     3,787,400 3,358,333 4,150,400 3,845,943        
Cantor Fitzgerald & Co. and Ladenburg Thalmann & Co. Inc. | Sales Agreement                    
Schedule Of Capitalization Equity [Line Items]                    
Common stock issued, net of expenses (in shares)     0 0 0 137,610        
Proceeds from common stock issued       $ 0   $ 700,000        
Aspire Capital | Common Stock Purchase Agreement                    
Schedule Of Capitalization Equity [Line Items]                    
Common stock issued, net of expenses (in shares)       0   375,000        
Proceeds from common stock issued       $ 0   $ 1,500,000        
Maximum | Aspire Capital | Common Stock Purchase Agreement                    
Schedule Of Capitalization Equity [Line Items]                    
Sale of common stock at sole discretion   $ 20,000,000.0                
April 2022 Public Offering                    
Schedule Of Capitalization Equity [Line Items]                    
Common stock issued, net of expenses (in shares) 3,333,333                  
Pre-funded warrants were exercised for proceeds     $ 3,787,000   $ 4,150,000          
Proceeds from common stock issued $ 41,800,000                  
April 2022 Public Offering | Pre-funded Warrants                    
Schedule Of Capitalization Equity [Line Items]                    
Common stock, par value (in dollars per share) $ 0.001                  
Common stock issued, net of expenses (in shares)     3,787,400   4,150,400          
Number of warrants issued to purchase common stock (in shares) 11,666,667   7,516,267 11,666,667 7,516,267 11,666,667        
Public offering price $ 2.999                  
April 2022 Public Offering | Common Stock                    
Schedule Of Capitalization Equity [Line Items]                    
Public offering price $ 3.00                  
April 2022 Public Offering | Maximum | Warrant [Member]                    
Schedule Of Capitalization Equity [Line Items]                    
Number of warrants issued to purchase common stock (in shares) 15,000,000